Literature DB >> 20469458

A rationale for the current management of post-menopausal osteoporosis.

G S Cohen.   

Abstract

Because of the potential impact on so many of our patients of post-menopausal osteoporosis, and the staggering costs the disease imposes on our health-care system, it behooves all family doctors to maintain an up-to-date approach to its management, including prevention as well as treatment. In a brief review of some aspects of bone metabolism, the author attempts to clarify why osteoporosis develops in post-menopausal women and to relate these causes to principles of management. He presents current experimental evidence in support of specific modalities (e.g., supplemental estrogen), and considers the relative risks of using these modalities. Finally, he raises a number of practical issues relating to the application of such routines into practice.

Entities:  

Year:  1986        PMID: 20469458      PMCID: PMC2327491     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  27 in total

1.  Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.

Authors:  L E Nachtigall; R H Nachtigall; R D Nachtigall; E M Beckman
Journal:  Obstet Gynecol       Date:  1979-03       Impact factor: 7.661

2.  Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study.

Authors:  T L Bush; L D Cowan; E Barrett-Connor; M H Criqui; J M Karon; R B Wallace; H A Tyroler; B M Rifkind
Journal:  JAMA       Date:  1983-02-18       Impact factor: 56.272

Review 3.  The menopause: benefits and risks of estrogen-progestogen replacement therapy.

Authors:  R D Gambrell
Journal:  Fertil Steril       Date:  1982-04       Impact factor: 7.329

4.  Treatment of osteoporosis: theoretical possibilities.

Authors:  A M Parfitt
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

5.  Nutritional factors and estrogen in age-related bone loss.

Authors:  R P Heaney
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

6.  Non-invasive measurements of bone loss in peripheral bones.

Authors:  H E Meema
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

7.  Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

Authors:  E Hirvonen; M Mälkönen; V Manninen
Journal:  N Engl J Med       Date:  1981-03-05       Impact factor: 91.245

8.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

9.  Influence of esterified estrogens and medroxyprogesterone on lipid metabolism and sex steroids. A study in oophorectomized women.

Authors:  L Mattsson; G Cullberg; G Samsioe
Journal:  Horm Metab Res       Date:  1982-11       Impact factor: 2.936

10.  Bone response to termination of oestrogen treatment.

Authors:  R Lindsay; D M Hart; A MacLean; A C Clark; A Kraszewski; J Garwood
Journal:  Lancet       Date:  1978-06-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.